Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $254.21 million. The enterprise value is $148.52 million.
| Market Cap | 254.21M |
| Enterprise Value | 148.52M |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 49.55 million shares outstanding. The number of shares has increased by 1.63% in one year.
| Shares Outstanding | 49.55M |
| Shares Change (YoY) | +1.63% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 21.78% |
| Owned by Institutions (%) | 51.43% |
| Float | 28.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.12 |
| Forward PS | 3.02 |
| PB Ratio | 2.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.29, with a Debt / Equity ratio of 0.28.
| Current Ratio | 13.29 |
| Quick Ratio | 12.44 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.25 |
Financial Efficiency
Return on equity (ROE) is -41.90% and return on invested capital (ROIC) is -37.16%.
| Return on Equity (ROE) | -41.90% |
| Return on Assets (ROA) | -30.60% |
| Return on Capital (ROIC) | -37.16% |
| Revenue Per Employee | $378,766 |
| Profits Per Employee | -$259,565 |
| Employee Count | 214 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, Sight Sciences has paid $110,000 in taxes.
| Income Tax | 110,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.13% in the last 52 weeks. The beta is 2.83, so Sight Sciences's price volatility has been higher than the market average.
| Beta (1Y) | 2.83 |
| 52-Week Price Change | -48.13% |
| 50-Day Moving Average | 4.84 |
| 200-Day Moving Average | 4.81 |
| Relative Strength Index (RSI) | 47.26 |
| Average Volume (30 Days) | 193,935 |
Short Selling Information
The latest short interest is 1.29 million, so 2.60% of the outstanding shares have been sold short.
| Short Interest | 1.29M |
| Short Previous Month | 1.63M |
| Short % of Shares Out | 2.60% |
| Short % of Float | 4.46% |
| Short Ratio (days to cover) | 9.23 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $81.06 million and -$55.55 million in losses. Loss per share was -$1.14.
| Revenue | 81.06M |
| Gross Profit | 69.18M |
| Operating Income | -57.27M |
| Pretax Income | -55.44M |
| Net Income | -55.55M |
| EBITDA | -48.41M |
| EBIT | -50.03M |
| Loss Per Share | -$1.14 |
Balance Sheet
The company has $138.13 million in cash and $33.93 million in debt, giving a net cash position of $104.20 million or $2.10 per share.
| Cash & Cash Equivalents | 138.13M |
| Total Debt | 33.93M |
| Net Cash | 104.20M |
| Net Cash Per Share | $2.10 |
| Equity / Book Value | 120.22M |
| Book Value Per Share | 2.43 |
| Working Capital | 150.62M |
Cash Flow
In the last 12 months, operating cash flow was -$47.18 million and capital expenditures -$791,000, giving a free cash flow of -$47.98 million.
| Operating Cash Flow | -47.18M |
| Capital Expenditures | -791,000 |
| Free Cash Flow | -47.98M |
| FCF Per Share | -$0.99 |
Margins
Gross margin is 85.34%, with operating and profit margins of -70.66% and -68.53%.
| Gross Margin | 85.34% |
| Operating Margin | -70.66% |
| Pretax Margin | -68.39% |
| Profit Margin | -68.53% |
| EBITDA Margin | -59.72% |
| EBIT Margin | -61.72% |
| FCF Margin | -59.19% |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.63% |
| Shareholder Yield | -1.63% |
| Earnings Yield | -21.98% |
| FCF Yield | -18.98% |
Analyst Forecast
The average price target for Sight Sciences is $5.00, which is -2.53% lower than the current price. The consensus rating is "Hold".
| Price Target | $5.00 |
| Price Target Difference | -2.53% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 5 |